Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Equity - Schedule of Stock Option Activity (Details)

v3.26.1
Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Feb. 01, 2026
Feb. 02, 2025
Number of options    
Number of options, outstanding, beginning balance (in shares) 495,366  
Number of options, issued (in shares) 0  
Number of options, forfeited (in shares) (110,081)  
Number of options, exercised (in shares) 0  
Number of options, outstanding, ending balance (in shares) 385,285 495,366
Number of options, exercisable at the end of the period (in shares) 385,285  
Weighted average exercise price    
Weighted average exercise price, outstanding balance (in dollars per share) $ 38.10  
Weighted average exercise price, issued (in dollars per share) 0  
Weighted average exercise price, canceled and forfeited (in dollars per share) 38.10  
Weighted average exercise price, exercised (in dollars per share) 0  
Weighted average exercise price, outstanding balance (in dollars per share) 38.10 $ 38.10
Weighted average exercise price, exercisable at the end of the period (in dollars per share) $ 38.10  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]    
Weighted average remaining contractual life, outstanding (in years) 3 years 4 months 2 days 4 years 4 months 2 days
Average intrinsic value, outstanding $ 0 $ 0
Average intrinsic value, exercisable $ 0